Manufacturer for Electric Portable Digital Display DC Compressor Nebulizer Asthma Inhaler Kit 8ml Capacity for Commercial

Description

Shenzhen Fitconn Technology Co.,ltd was founded in 2012 . It is a comprehensive enterprise dedicated to the research and development, manufacturing, sales and after-sales service of household medical products. The products cover nebulizer (compressor nebulizer, DC Compressor nebulizer and Mesh nebulizer), anti-decubitus air mattress, oximeters, fetal doppler, blood pressure monitors, etc. The business covers more than 150 countries around the world, with an average annual service of more than 2,000,000 family. Fitconn adheres to the concept of create health by heart, and is committed to improving the diversification of atomization methods, let’s households medical products and modern medical technology can benefit thousands of families around the world, with respect, tolerance, integrity, efficiency, innovation and persistence as core values, Integrate superior resources, take innovation as the source of development, and take science and technology as the foundation of success, and strive to provide each consumer with more professional, advanced and safer medical products. Fitconn has the class II medical device production qualification and over 50 patents , the company has passed the 13485 quality system certification, and some products have passed the EU CE and FDA certification

Fitconn CDC300S: When a Compressor Nebulizer Decides to Think Like a Mesh Device

The 0.35 Micron Surprise

Here is a specification that does not belong on a compressor nebulizer: 0.35 μm MMAD.

Let that sink in. Most compressor units deliver particles in the 3 to 5 micron range and call it a day — perfectly adequate for upper and mid-airway treatment. A particle size of 0.35 micrometers is the kind of number you expect from a premium ultrasonic mesh device, not from a piston-driven compressor that plugs into the wall. Yet the Fitconn CDC300S, a DC compressor nebulizer no larger than a shoebox, produces an aerosol mist fine enough to reach the deepest alveolar structures — the terminal bronchioles where gas exchange actually happens.

This is not a marginal improvement on a spec sheet. It is a fundamental redefinition of what a compressor nebulizer can do. For clinical applications involving medications that require deep-lung deposition — certain antibiotics, surfactant therapies, or advanced biologic aerosols — the CDC300S opens a treatment pathway that previously required far more expensive equipment. Fitconn has effectively collapsed the cost gap between compressor reliability and mesh-level particle precision into a single device.

Silence Is the New Performance Metric

If sub-micron particle delivery is the headline, the ≤50 dB(A) noise rating is the paragraph right beneath it that deserves its own headline. Fifty decibels is the sound of a quiet library, a refrigerator hum, or light rainfall outside a window. It is not the sound most people associate with a compressor nebulizer — those devices have historically announced their presence with a chugging, vibrating racket that makes bedtime treatments a household ordeal.

The CDC300S, at under 50 dB, can run a full 30-minute cycle in a darkened nursery without waking a sleeping child. It can sit on an office desk during a lunch-break treatment without broadcasting to the entire floor. This matters because adherence to respiratory therapy is notoriously fragile — every obstacle, noise included, is a reason to skip a session. A quiet device is not a luxury feature; it is a compliance enabler.

The 8 mL Cup and the 0.8 mL Promise

Fitconn has carried over the low-residual design philosophy from the CNB69031S into the CDC300S. The medication cup holds a generous 8 mL, enough for extended-duration treatments, yet the residual volume after a full cycle is less than 0.8 mL. That is a utilization rate that makes pharmacists smile — less medication down the drain, fewer refills, lower lifetime cost for the patient or the institution footing the bill.

Pair this with the triple-mode digital timer — selectable at 10, 20, or 30 minutes — and you have a system where the machine does the thinking. Set the duration, press start, walk away. The CDC300S counts down in real time on its crisp digital display and shuts off automatically. No over-nebulization, no dry-running the compressor, no hovering with a stopwatch. The device manages its own duty cycle so the caregiver does not have to.

DC Compressor, Global Voltage

The power architecture is quietly brilliant: AC 100–240V, 50/60Hz — the universal voltage range that works in every outlet on the planet without a transformer. Toss it in a suitcase with a plug adapter and it is ready for use in London, Lagos, or Lima. The internal DC compressor sustains a 40–80 KPA pressure range with a steady gas flow of ≥5 L/min, delivering consistent nebulization at ≥0.2 mL/min regardless of local grid fluctuations.

At 2.0 kg and packaged in a compact 25 x 21 x 23 cm box, the CDC300S lands in that sweet spot between "portable enough to move room to room" and "substantial enough to feel like real medical equipment." The ABS plastic shell comes in white or gray, understated and clinical without being cold.

Certifications That Do the Talking

The CDC300S carries the full Fitconn regulatory stack: CE, ISO 13485, MDR EU, RoHS, and 93/42/EEC. ISO 13485 is the one that procurement officers circle with a pen — it is the gold-standard quality management certification specific to medical device manufacturing, and it signals that the factory operates under audited, documented, repeatable processes. This is not a product assembled in a converted warehouse. This is a medical instrument built in a facility that has passed the same certification rigor as the world's largest device manufacturers.

With online technical support included, downstream buyers get a product they can sell with confidence and end-users get a device they can rely on.

Who Is This For, Really?

The CDC300S makes the most sense for three types of buyers.

First, distributors in markets where clinical expectations are rising faster than budgets — regions where patients are beginning to demand hospital-grade outcomes at home-care prices. The 0.35 μm particle size is a specification that separates the CDC300S from every generic compressor nebulizer on the shelf, and that difference translates directly into retail shelf appeal.

Second, home healthcare providers managing patients with progressive respiratory conditions — COPD, cystic fibrosis, severe asthma — where medication must reach deep into the lung and treatment sessions are measured in decades, not weeks. The quiet operation, the low residual waste, and the universal voltage all compound into long-term value that a cheaper, louder unit simply cannot match.

Third, private-label brands looking for a flagship product in their respiratory care line. The CDC300S is not the entry-level model — it is the one you put at the top of the catalog with the "Professional Grade" badge. It justifies a premium retail price because its specifications are genuinely premium.

One Line to Remember

Most nebulizers ask the patient to adapt to the machine. The CDC300S is one of the rare devices where the machine has clearly been designed to adapt to the patient — quieter than a conversation, finer than a mesh, and smart enough to know when to stop. That is not marketing language. That is what the spec sheet says.